Numerous diseases are growing all over the world. Doctors and scientists are inventing cost-friendly and effective ways to treat different kinds of growing diseases. In this initiative, the Indian government is working towards using allopathy and Ayurveda for curing diseases and bringing about a change in the healthcare industry. In the treatment of many diseases, allopathy and Ayurveda was implemented and experimented to study the outcomes and it was positively successful. About 10 lakh patients have been screened so far under this program, which was launched extensively in 2017. Of these, nearly 93,000 patients were chosen for long-term care. Experts believe that 60 percent of the country’s total deaths are responsible for these diseases. So now the government is planning for its expansion all over the world.
For the treatment of chronic diseases, minor illnesses and rare diseases the government had started The National Program for NPCDCS. Under this, the first time an agreement was signed between the Ministry of Health and Family Welfare and Ministry of AYUSH to include Ayurveda in creating medicines. After this, pilot projects have been released in six districts including Gaya in Bihar, Bhilwara of Rajasthan, Lakhimpur Kheri in Uttar Pradesh.
Last week, in the Rajya Sabha, Ayush Minister Shripad Naik said that authentic Ayurvedic medicines have been developed for diabetes, cancer, kidney and heart disease, which have proved to be quite effective. NBRI and CIAMP developed Ayurvedic medicine called BGR-34 for the effective treatment of diabetes, under the Council of Scientific and Industrial Research (CSIR).In the care of type 2 diabetes, it has been found to be medically true.
At the same time, a medicine called Ayush-QOL-2C from the Ayurvedic formula was created by the Central Council for Research in Ayurvedic Sciences (CCRAS). This ayurvedic medicine and allopathy are used in AIIMS, Delhi and Johns Medical College to improve the lives of breast and cervical cancer patients.
As this progress of Ayurveda medicine slowly progresses, it will be widely used in all sectors of healthcare.